Lagana', Marta
 Distribuzione geografica
Continente #
NA - Nord America 2.164
AS - Asia 1.347
EU - Europa 1.201
SA - Sud America 264
AF - Africa 31
OC - Oceania 2
Totale 5.009
Nazione #
US - Stati Uniti d'America 2.105
SG - Singapore 593
CN - Cina 299
IT - Italia 273
PL - Polonia 240
BR - Brasile 221
HK - Hong Kong 163
DE - Germania 155
FI - Finlandia 145
VN - Vietnam 102
GB - Regno Unito 74
IE - Irlanda 61
TR - Turchia 56
RU - Federazione Russa 55
UA - Ucraina 49
CA - Canada 31
SE - Svezia 31
BD - Bangladesh 27
IN - India 27
ID - Indonesia 25
MX - Messico 20
FR - Francia 19
CZ - Repubblica Ceca 18
NL - Olanda 17
AR - Argentina 16
BE - Belgio 14
ZA - Sudafrica 14
JP - Giappone 12
ES - Italia 11
AT - Austria 9
EC - Ecuador 9
CH - Svizzera 8
DZ - Algeria 6
PT - Portogallo 6
CL - Cile 5
LT - Lituania 5
MA - Marocco 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
IQ - Iraq 4
CR - Costa Rica 3
LB - Libano 3
LV - Lettonia 3
PK - Pakistan 3
PY - Paraguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
AZ - Azerbaigian 2
CY - Cipro 2
GY - Guiana 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
RO - Romania 2
TW - Taiwan 2
ZW - Zimbabwe 2
AL - Albania 1
AU - Australia 1
BO - Bolivia 1
CO - Colombia 1
EE - Estonia 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
UY - Uruguay 1
Totale 5.009
Città #
Singapore 263
Warsaw 237
Ashburn 236
Dallas 232
Hong Kong 163
Fairfield 121
Los Angeles 102
Helsinki 99
New York 99
Beijing 96
Chandler 92
Chicago 66
Munich 61
Wilmington 53
Seattle 52
Princeton 45
Istanbul 44
Houston 43
Woodbridge 43
Cambridge 38
Dalmine 37
Jacksonville 36
Boardman 35
Brescia 35
Turku 35
Buffalo 32
Redondo Beach 30
Secaucus 30
Dublin 27
Moscow 26
Ho Chi Minh City 25
Dong Ket 24
Jakarta 24
Milan 24
Salt Lake City 24
Menlo Park 22
San Francisco 22
West Jordan 20
Des Moines 19
Shanghai 19
The Dalles 19
Hanoi 18
London 17
Nuremberg 17
São Paulo 17
Ann Arbor 15
Brno 15
Santa Clara 15
Brussels 14
Naples 14
Poplar 14
Stockholm 14
Elk Grove Village 13
Boston 12
Brooklyn 12
Orem 12
Rio de Janeiro 12
Johannesburg 11
Romola 11
Tampa 11
Lappeenranta 10
Montreal 9
Pune 9
Atlanta 8
Phoenix 8
Tokyo 8
Turin 8
Biên Hòa 7
Dulles 7
Düsseldorf 7
San Diego 7
Tianjin 7
Toronto 7
Ankara 6
Brasília 6
Dearborn 6
Denver 6
Frankfurt am Main 6
Livorno 6
Rome 6
Sterling 6
Curitiba 5
Jinan 5
Manchester 5
New Delhi 5
Querétaro 5
Raleigh 5
São Bernardo do Campo 5
Venice 5
Zhengzhou 5
Amsterdam 4
Calcinate 4
Campinas 4
Caxias do Sul 4
Chennai 4
Dhaka 4
Guangzhou 4
Leipzig 4
Miami 4
Mumbai 4
Totale 3.249
Nome #
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 359
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 223
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 195
Immunotherapy failure in adrenocortical cancer: where next? 194
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 169
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 158
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 155
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 151
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 143
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 118
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 111
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases 110
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 106
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 102
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 101
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 99
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 97
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 94
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 91
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 91
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 88
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 87
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 86
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 84
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 82
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 80
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 80
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis 79
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 78
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma 78
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 78
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 76
Changes in body composition in early breast cancer patients treated with aromatase inhibitors 75
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 73
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 73
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 73
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 70
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies 68
Oncological treatment administration at end of life: a retrospective study 66
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 65
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 65
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report 63
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 62
The Evolving Treatment Landscape of Medullary Thyroid Cancer 60
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 60
Adjuvant denosumab for early breast cancer-Evidence and controversy 58
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma 52
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 51
null 51
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 42
Cardiovascular and metabolic comorbidities in patients with thyroid nodules: the impact of incidental diagnosis 40
Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study 38
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic tool 35
Venous thromboembolism in adrenocortical carcinoma: a retrospective analysis 33
Fragility fractures in well-differentiated gastroenteropancreatic neuroendocrine tumors: Results from a multicentered retrospective study 4
Totale 5.120
Categoria #
all - tutte 27.078
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.078


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021286 0 0 0 0 0 63 20 51 31 52 26 43
2021/2022275 20 10 7 66 15 12 13 11 13 36 23 49
2022/2023249 31 16 18 15 19 51 4 27 26 8 17 17
2023/2024595 25 19 45 53 55 97 19 32 86 39 15 110
2024/20251.594 51 31 20 266 140 90 114 67 193 90 393 139
2025/20261.643 238 361 376 340 289 39 0 0 0 0 0 0
Totale 5.120